All Articles: Announcements

Robert Vince, PhD, director of the Center for Drug Design at the University of Minnesota, has been selected as the 2022 Lawrence C. and Delores M. Weaver Medal recipient.

Honor bestowed on behalf of the advancement of science or its applications that are scientifically or socially distinguished.

Congratulations to Dr. Natalia Tretyakova, who has been selected as a 2018 Distinguished McKnight University Professor!

Jay's research focuses on the determination of known genetic variations within Very Important Pharmacogenes (VIPs) in the Hmong population which brings local, state-wide and regional relevance to the nationally supported NIH “Precision Medicine Initiative”.

Welocome to our newest member, Debra Skaar, PharmD, FCCM.  She is an Associate Professor in Experimental and Clinical Pharmacology.  Read her hio here. 

Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.

Siddhee Sahasrabudhe, CODR graduate student, earned two additional certificates recently: NIH ethics and regulatory affairs and TACA pharmacometrics statistics.

Congratulations Siddhee on your continued commitment to pursuing knowledge!

As part of her being named a Rare Disease Difference Maker, Dr. Reena Kartha was interviewed by Engage Health. She shared her path to the rare disease field and more about her innovative undergraduate course which was a huge factor to her being nominated.

Dr. Carrie Haskell-Luevano loves being a researcher. As a professor and Philip S. Portoghese Endowed Chair in Chemical Neuroscience, she finds joy in teaching students and making discoveries alongside her laboratory staff. Read about the value she finds in her partnership with UMN Technology Commercialization.

Program to catalyze and support adoption of pharmacogenomics on a national scale.